Funder
Genome Canada
Centre for Genetic Medicine
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Public Health, Environmental and Occupational Health,Epidemiology
Reference9 articles.
1. Buchanan J, Wordsworth S, Schuh A (2013) Issues surrounding the health economic evaluation of genomic technologies. Phamacogenomics 14:1833–1847. https://doi.org/10.2217/pgs.13.183
2. CADTH (2017) Guidelines for the economic evaluation of health technologies: Canada. 4th ed. CADTH, Ottawa
3. Jani M, Gavan S, Chinoy H, Dixon WG, Barton A, Harrison B, Moran A, Barton A, Payne K (2016) A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice. Rheumatology 55:2131–2137. https://doi.org/10.1093/rheumatology/kew292
4. Jegathisawaran J, Tsiplova K, Marshall CR, Stavropoulos DJ, Pereira S, Thiruvahindrapuram, B, Ungar WJ (2018) A microcosting and cost-consequence analysis of genomic testing strategies (including trios) in austim spectrum disorder: an update. http://lab.research.sickkids.ca/task/reports-theses/. Accessed 14 Feb 2019
5. Phillips KA, Pletcher MJ, Ladabaum U (2015) Is the “$1000 genome” really $1000? Understanding the full benefits and costs of genomic sequencing. Technol Health Care 23:373–379. https://doi.org/10.3233/THC-150900
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献